Publications
Logistics and programmatic issues related to new vaccine introduction
Risk of Intussusception Following Administration of a Pentavalent Rotavirus Vaccine in US Infants
The study examines the risk of intussusception following pentavalent rotavirus vaccine (RV5) in US infants and concludes that among US infants aged 4 to 34 weeks who received RV5, the risk of intussusception was not increased compared with infants who did not receive the rotavirus vaccine.
| Wed May 30 @08:00 Vaccine-derived Polioviruses: Scientific meeting |
| Mon Jun 04 @08:00 Vaccine production summit |
| Tue Jun 05 @08:00 Webinar: Trends in Cold Chain Temperature Monitoring |
| Mon Jun 11 @08:00 Regional review workshop on rotavirus and VP-IBDs surveillance |